| November 3 |
Over 60 Million U.S. Adults Engaging in Health 2.0 |
| November 3 |
Tweens and Teens Double Use of Diabetes Drugs |
| November 3 |
Daiichi Sankyo Acquires Merck Serono's Cardio-Metabolism Sales Force and Products in Turkey |
| November 3 |
Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter |
| November 3 |
Avigen Announces Restructuring and Strategic Direction |
| November 4 |
John Patterson to Retire from AstraZeneca |
| November 4 |
Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products |
| November 4 |
Replidyne and Cardiovascular Systems Sign Merger Agreement |
| November 4 |
Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra and Launches Immediately |
| November 5 |
Westaim Terminates Reorganization Agreement and Cancels Shareholders' Meeting |
| November 5 |
Drug Companies Gave Vermont Health Care Providers Gifts Worth $4.9 Million Over Two Years |
| November 5 |
Grassley Calls on FDA Leaders to Address Mismanagement of FDA Employee Pay and Benefits |
| November 5 |
Hospira Reports Third-Quarter 2008 Results |
| November 5 |
ImClone Systems Announces Expiration of Hart-Scott-Rodino Waiting Period |
| November 5 |
Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation |
| November 5 |
Urigen Outlines Operating Plans |
| November 6 |
FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes |
| November 6 |
King Pharmaceuticals Reports Third-Quarter 2008 Financial Results |
| November 6 |
Pfizer Discontinues Development Program for Its Phase 3 Obesity Compound (CP-945,598) |
| November 6 |
Teva Reports Third Quarter 2008 Results |
| November 6 |
Devgen announces the intention to close its pharma division and to fully focus on the development of its agro business |
| November 6 |
Sanofi-aventis to Discontinue all Clinical Trials with rimonabant |
| November 6 |
Teva Updates 2008 Financial Outlook |
| November 7 |
FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer |
| November 7 |
Express Scripts Warns of Potential Large Data Breach Tied to Threat |
| November 7 |
Novo Nordisk Invests Close to 400 Million US Dollars in New Insulin Production Plant in China |
| November 7 |
Amgen Positioned to Deliver Attractive Growth Over Next Five Years |
| November 7 |
CHI Congratulates Congressional Election Winners |
| November 10 |
Sanofi Pasteur First International Vaccine Company to Enter Japan With Pediatric Vaccine ActHIB (Haemophilus Influenzae Type b Vaccine) Available in Japan on December 19, 2008 |
| November 10 |
Crestor Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study |
| November 10 |
Biovest International Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize its Drugs and Technologies |
| November 11 |
Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction |
| November 11 |
Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring |
| November 11 |
ASI Announces Results of Advertising Specialties Impression Study |
| November 11 |
New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug |
| November 12 |
Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants |
| November 12 |
GeneNews Restructures Operations |
| November 12 |
FDA Approves 30-Minute Onset of Action for Focalin XR |
| November 12 |
Express Scripts Reports New Threats Tied to Data Security Breach |
| November 12 |
GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc. |
| November 13 |
FDA Updates the Early Communication about the Ongoing Safety Review of Bisphosphonates |
| November 13 |
FDA Warns Public of Extortion Scam by FDA Impersonators |
| November 13 |
Pharmaceutical Industry Needs To Speed Up Transformation To Meet Changing Market Dynamics, According To Ernst & Young Report |
| November 13 |
FDA Warns Public of Extortion Scam by FDA Impersonators |
| November 13 |
FDA MedWatch- Bisphosphonates-Update To The Early Communication Issued Regarding Atrial Fibrillation With Bisphosphonates |
| November 13 |
Public Statement On Exubera (Insulin Human) Withdrawal Of The Marketing Authorisation In The European Union |
| November 13 |
Novo Nordisk Launches Levemir Satisfaction Guarantee Program |
| November 14 |
Actavis Comments on Filing of DOJ Complaint |
| November 14 |
Pfizer Launches Global Regenerative Medicine Research Unit |
| November 14 |
Valeant Pharmaceuticals Acquires DermaTech |
| November 14 |
Senate Finance Chairman Baucus Unveils Blueprint for Comprehensive Health Care Reform |
| November 14 |
The U.S. Remains Preferred Market for Launching New Products |
| November 14 |
Javelin Pharmaceuticals Announces 15 Percent Reduction in Workforce |
| November 17 |
Roche, Merck Serono and Abbott Join Forces in Biotechnology Cluster Rhine-Neckar (BioRN) |
| November 17 |
FDA Approves Banzel (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder |
| November 17 |
Out-of-Pocket Costs Grow in Medicare Part D |
| November 17 |
FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint |
| November 17 |
Solvay Pharmaceuticals Discontinues R&D Activities of its Anti-Obesity Compound SLV319 |
| November 17 |
Progenics Announces Wyeth Has Received Relistor Approval in Australia |
| November 17 |
BioSante Pharmaceuticals Announces Receipt of NIH Grant for Inhaled Interferon |
| November 17 |
Mortara Instrument Announces Extension of ECG Warehouse CRADA With US FDA |
| November 18 |
ImClone Systems Announces Clearance of Tender Offer by German FederalCartel Office |
| November 18 |
Genentech Issues Dear Healthcare Provider Letter Regarding a2nd Case of PML in a Raptiva Patient |
| November 18 |
ACI’s FDA Boot Camp is the industry standard in providing non-regulatory professionals with the regulatory foundation critical to success |
| November 18 |
Manhattan Research Releases Report on the Future of Physician Customer Service Portals |
| November 18 |
AstraZeneca Appoints Rich Fante as President of its U.S. Business |
| November 18 |
I'm Sticking With My Brand: Loyal Customers Perceive Competitor Ads Differently |
| November 18 |
Study Finds Cost of Diabetes in the United States Exceeds $217 Billion |
| November 18 |
Sanofi-Aventis Pharma S.A. Withdraws Its Application for an Extension of Indication for Taxotere and Docetaxel Winthrop (docetaxel) |
| November 18 |
Public Statement on Forcaltonin - Withdrawal of the Marketing Authorisation in the European Union |
| November 18 |
Telephone Counseling May Improve Effectiveness of Varenicline (Chantix), According to Free & Clear Study |
| November 18 |
ACP Guideline Finds No Substantial Differences Among “Second-Generation” Antidepressants |
| November 19 |
Novartis highlights innovative approach to drug discovery with dynamic advance in exploratory pipeline |
| November 19 |
Barr Announces Agreements on Nasacort AQ, Allegra D-12 and Allegra Patent Challenges |
| November 19 |
ADHD Medications Do Not Cause Genetic Damage In Children |
| November 19 |
Teva Receives First U.S. Approval for Generic Pulmicort Respules;Commences Commercial Launch |
| November 19 |
Widely-Used Cancer Drug Associated With Significantly Increased Risk of Blood Clots |
| November 19 |
Prescription Project Welcomes U.S. Appeals Court Ruling in “Data-Mining” Case |
| November 19 |
Nevada Attorney General Cortez Masto Files Suit Against Hormone Therapy Drug Manufacturers |
| November 19 |
IMS v. Ayotte - Physician Privacy Law Upheld as Constitutional by First Circuit |
| November 19 |
Media Statement re: New Hampshire's Decision to Overturn a New Hampshire U.S. District Court Ruling that Struck Down the State’s Law Banning the Commercial Use of Prescriber-Identifiable Data |
| November 19 |
AstraZeneca Enters Agreement for Authorized Generic Pulmicort Respules |
| November 19 |
WebMD and Marketing Technology Solutions Terminate Merger Agreement |
| November 19 |
Ambrilia Initiates Plan Aiming to Significantly Reduce its Operations in France |
| November 19 |
Orion to Renew Operational Model of Pharmaceutical R&D. Negotiation Proposal on Reduction of up to 300 Employees in Finland |
| November 20 |
Pfizer Withdraws Application to Switch Viagra to Non-PrescriptionStatus in Europe |
| November 20 |
BIO Congratulates Former Senator Tom Daschle on His Nomination toServe as HHS Secretary |
| November 20 |
ImClone Systems' State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production |
| November 20 |
FDA Advisory Committee Provides Opinion on Oritavancin for theTreatment of Complicated Skin and Skin Structure Infections |
| November 20 |
AstraZeneca to Realign Supply Chain to Improve Productivity and Move Closer to Customers |
| November 20 |
Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer |
| November 20 |
AstraZeneca Granted Temporary Restraining Order in Pulmicort Respules Patent Litigation |
| November 20 |
New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness |
| November 20 |
Cervarix, GSK’s Cervical Cancer Vaccine, Wins Tender for Dutch National Immunisation Programme |
| November 20 |
FDA Sends Warning Letter to Shionogi Over Cedax Direct Mailers |
| November 20 |
European Medicines Agency Recommends the Suspension of the Marketing Authorisation of Ionsys (fentanyl hydrochloride) |
| November 20 |
FDA Sends Letter to Protherics Over Voraxaze Web Material |
| November 20 |
Internet Advertising Revenues in Q3 ’08 at Nearly $5.9 Billion |
| November 21 |
Vical Announces Strategic Restructuring and Staff Reduction |
| November 21 |
SurModics Announces Changes to Its Organizational Structure and Cost-Cutting Initiatives |
| November 21 |
Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension |
| November 21 |
CombinatoRx Concentrates on Core Strengths |
| November 21 |
Lilly Completes Cash Tender Offer for ImClone Systems |
| November 21 |
Nplate (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union |
| November 21 |
MINRAD International, Inc. Announces Reduction in Workforce |
| November 21 |
CHMP Posts 12 Opinions |
| November 21 |
Physicians Anticipate Higher Prescribing Based on JUPITER Study |
| November 21 |
Barr Shareholders Approve Pending Teva Acquisition |
| November 21 |
New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes |
| November 24 |
Labopharm's NDA for Novel Trazodone Formulation Accepted for Review by FDA |
| November 24 |
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix |
| November 24 |
PhRMA Statement on New National Advertising Campaign |
| November 24 |
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion |
| November 24 |
FDA Extends Review of Somaxon Pharmaceuticals' New Drug Application for Silenor (Doxepin) by up to Three Months |
| November 24 |
XDx Announces Strategic Restructuring |
| November 24 |
Lilly Completes Acquisition of ImClone Systems |
| November 24 |
Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects |
| November 24 |
Genzyme Seeks U.S. Approval for Clolar to Treat Adult AML |
| November 25 |
AstraZeneca Provides Update on Agreement with Abraxis Biosciences for Co-Promotion of Abraxane in the US |
| November 25 |
Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals |
| November 25 |
Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr |
| November 25 |
Antitrust: European Commission Confirms Unannounced Inspections at Pharmaceutical Companies |
| November 25 |
Anika Therapeutics Terminates Contract with U.S. Distribution Partner for ELEVESS |
| November 25 |
Bayer Healthcare to Pay U.S. $97.5 Million to Settle Allegations of Paying Kickbacks to Diabetic Suppliers |
| November 25 |
Bayer Healthcare llc Reaches Settlement with U.S. Department of Justice on Investigation into former Diabetes Care Marketing Programs |
| November 26 |
FDA Sends Warning Letter to Actelion Over Tracleer Flash Card |
| November 26 |
Use Of Inhaled Corticosteroids For Copd Does Not Appear To Improve Survival, But May Increase Risk For Pneumonia |
| November 26 |
FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections |
| November 26 |
Pfizer's Novel HIV/AIDS Treatment Selzentry Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients |
| November 26 |
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease |
| November 26 |
Growth hormone not beneficial for ALS |
